The assay detects a mutation that can confer hearing loss in patients, particularly neonates, who have taken gentamicin, an antibiotic prescribed for certain bacterial infections.
The effort is already bearing fruit, as the team has been able to validate several variants known to be connected with adverse drug reactions.
At last week's ESHG annual meeting, three quality assessment providers discussed best practice guidelines and results from a pilot NIPT quality assessment scheme.
At the European Society of Human Genetics annual meeting in Copenhagen this week, several groups presented studies involving automated facial analysis software.
The SeqStudio instrument, which has a list price of $57,000, uses a click-in cartridge with four capillaries that comes pre-loaded with polymer and buffer.
Paralogs may compensate for a mutated gene in tissues other than the disease-affected ones, researchers from Ben-Gurion University of the Negev in Israel found.
The company launched an updated version of its Face2Gene software suite earlier this month at the American Society of Human Genetics annual meeting.
The results were presented at the ESHG meeting in Scotland this weekend and could potentially influence how NIPT is offered in those countries.
The groups acknowledge the value in NIPT, but recommend against expanding testing for sex chromosomal aneuploidies and microdeletions.
The European Society for Human Genetics has issued recommendations for laboratories performing clinical whole-genome sequencing.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.